Meet us in Nice at the XXVII EFMC International Symposium on Medicinal Chemistry which will take place from September 4-8, 2022.
The 2022 program will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer. The conference will also feature most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues.
Our Business Development team will be there ready to answer any question you may have about ZoBio.
Looking forward to meeting you in Nice!
ZoBio is proud to be one of the sponsors of 14th Swiss Course on Medicinal Chemistry in Leysin!
This five-day Medicinal Chemistry School is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society and will focus on most modern aspects associated with small molecule drug discovery, highlighting the methodologies and technologies supporting hit generation, lead finding and lead optimization campaigns.
As in previous years, the teaching content will be targeted at young scientists working in the area of medicinal chemistry, but also from flanking disciplines such as biochemistry, pharmacy, pharmacology, or biophysics from the pharmaceutical and biotech industry.
ZoBio is delighted to contribute to this special event. On Wednesday 12 October our CEO Gregg Siegal will talk about application of Biophysics in Modern Drug Discovery. Marta Carneiro (Head of Structural Biology) is one of the tutorial leaders. They will share their knowledge using biophysics in various aspects of drug discovery with the next generation of drug hunters.
Looking forward to meeting you in Leysin!
As in the previous years ZoBio attended the European Conference on Magnetic Resonance, which took place in Utrecht on the 10-14 July 2022.
The organizers provided a stimulating forum to exchange on the most recent breakthroughs in magnetic resonance and to showcase the latest developments of the industrial sponsors.
On Tuesday 12 July Gregg Siegal, CEO of ZoBio gave the talk ‘NMR (and biophysics) in drug discovery: Effectiveness vs Elegance’.
On July 7th Dipen Shah, our Head of Protein Sciences attended the Protein Society Annual Symposium in San Francisco, California. Dipen presented the poster: From Genes to Lead Molecules: a work-flow tuned for drugging challenging therapeutic targets using Fragment based Drug Discovery.
This year symposium comprised 12 exceptional scientific sessions and nine award speakers totaling over 60 invited and contributed talks. The symposium provided an overview of developments in protein science, combining critical underpinnings of the field, the latest developments, and a vision into the future with career development and technical workshops as well as ample networking opportunities.
Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists.
Our CEO Gregg Siegal attended the event and participated in many interesting and educational discussions.